Grifols Earns 177 Million Until June, Almost Five Times as Much, and Its Revenues Grow by 7%.
5 Articles
5 Articles
Grifols has earned EUR 177 million until June, almost five times as much, and its revenues grow by 7%.
The hemoderivative manufacturer will pay its shareholders €0.15 per share in August, its first dividend since June 2021. The company raised sales by 7%, to €3,677 million and continues to reduce its indebtedness. Read
Grifols earns 177 million euros in the first six months of the year, 387.6% more than in the first half of 2024, which means that five times the profits of 36 million registered in the same period of the previous year. Revenues for the first semester of the year grew by 7% to reach 3,677 million euros, driven by the solid performance of Biopharma's business, which recorded a growth of 8.2%. Adjusted ebitda stood at 876 million euros, representin…
Grifols earns 177 million euros in the first six months of the year, 387.6% more than in the first half of 2024. Revenues for the first half of the year grew by 7% to reach 3,677 million euros, driven by the strong performance of Biopharma's business, which recorded a growth of 8.2%. Adjusted ebitda stood at 876 million euros, representing an increase of 12.7% over the same period of the previous year, with a margin of 23.8%, supported by the co…
The hemoderivative giant has returned to the path of the dividend after agreeing the payment of 0.15 euros per share and reduced its leverage to 4.2 times at the end of the period
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium